Cas:548-76-5 Irigenin manufacturer & supplier

We serve Chemical Name:Irigenin CAS:548-76-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Irigenin

Chemical Name:Irigenin
CAS.NO:548-76-5
Synonyms:5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxychromen-4-one;7,5,3′-Trihydroxy-6,4′,5′-trimethoxyisoflavon;5,7,3′-trihydroxy-6,4′,5′-trimethoxyisoflavone;Irigenin;EINECS 208-958-3
Molecular Formula:C18H16O8
Molecular Weight:360.31500
HS Code:2914509090

Physical and Chemical Properties:
Melting point:189-192ºC
Boiling point:646.1ºC at 760mmHg
Density:1.461g/cm3
Index of Refraction:1.649
PSA:118.59000
Exact Mass:360.08500
LogP:2.60260

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxychromen-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 208-958-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Irigenin Use and application,5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxychromen-4-one technical grade,usp/ep/jp grade.


Related News: In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better. Irigenin manufacturer For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. Irigenin supplier An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. Irigenin vendor An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. Irigenin factory In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better.